Modulators of calcium signalling in neuronal physiology and disease

Simple item page
dc.contributor.authorGrant, Jeff
dc.contributor.examiningcommitteeFernyhough, Paul (Pharmacology and Therapeutics) Parkinson, Fiona (Pharmacology and Therapeutics) Amara, Francis (Biochemistry and Medical Genetics) Cashman, Neil (University of British Columbia)en
dc.contributor.supervisorMayne, Michael (Pharmacology and Therapeutics)en
dc.date.accessioned2008-09-11T21:58:15Z
dc.date.available2008-09-11T21:58:15Z
dc.date.issued2008-09-11T21:58:15Z
dc.degree.disciplinePharmacology and Therapeuticsen_US
dc.degree.levelDoctor of Philosophy (Ph.D.)en_US
dc.description.abstractThis thesis focuses on the regulation of the ubiquitous second messenger Ca2+ in neuronal physiology and disease. Ca2+ signalling in neurons is regulated by ion channels located in the plasma membrane, as well as in the endoplasmic reticulum (ER) and mitochondrial membranes. Ca2+ signalling is essential for numerous cellular processes, including neuronal excitability, neurotransmitter release, synaptic plasticity, and induction of cell death. Age-related disruptions in Ca2+ signalling may contribute to decline of cognitive function and motor control associated with aging. Furthermore, disruption in neuronal Ca2+ signalling is implicated in several neurodegenerative disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and Amyotrophic Lateral Sclerosis (ALS). In this thesis, I studied neuronal Ca2+ signalling and how it is affected in neurodegenerative disease. First, I examined the role of the ER Ca2+ binding protein Calreticulin (CRT) in AD. CRT is involved in regulation of ER Ca2+ signalling and modulation of susceptibility to cell death. I found that there was an increase in the expression of CRT in in vitro and in vivo models of AD. However, increased levels of CRT did not alter susceptibility of neuronal cells to death induced by AD-related stressors. Second, I examined the role of X-Linked Inhibitor of Apoptosis Protein (XIAP) in the modulation of neuronal Ca2+ signalling. I found that overexpression of XIAP in neuronal cells modified Ca2+ signalling by decreasing Ca2+ flux through multiple plasma membrane and ER channels. These effects appear to be independent of caspase inhibition, which is one of the ways that XIAP can inhibit apoptosis. Third, I examined a compound found in green tea, L-theanine, a glutamate receptor antagonist that is protective in models of excitotoxic neuronal injury. I found that 24 hour L-theanine treatment reduces the amount of Ca2+ released from neuronal intracellular stores in response to both glutamate stimulation and passive leak through ER channels. An acute 30 minute L-theanine treatment had similar effects. In conclusion, these observations further the understanding of the regulation of Ca2+ signalling in neurons and may lead to novel therapeutic strategies in neurodegenerative disease.en
dc.description.noteOctober 2008en
dc.format.extent1341834 bytes
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://hdl.handle.net/1993/3073
dc.language.isoengen_US
dc.rightsopen accessen_US
dc.subjectcalciumen
dc.subjectneuronen
dc.subjectXIAPen
dc.subjectCalreticulinen
dc.subjectL-Theanineen
dc.subjectAlzheimer's diseaseen
dc.subjectneurodegenerationen
dc.titleModulators of calcium signalling in neuronal physiology and diseaseen
dc.typedoctoral thesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Modulators of Calcium Signalling in Neuronal Physiology and Disease.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.33 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
FGS - Electronic Theses and Practica